Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer-Reference-Cited by-同舟云学术

Novel biomarker panel predicts prognosis in human papillomavirus-negative oropharyngeal cancer

Published:2011-08-25 Issue:7 Volume:118 Page:1811-1817
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Wu Yin,Posner Marshall R.,Schumaker Lisa M.,Nikitakis Nikolaos,Goloubeva Olga,Tan Ming,Lu Changwan,Iqbal Sana,Lorch Jochen,Sarlis Nicholas J.,Haddad Robert I.,Cullen Kevin J.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference44 articles.

1. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

2. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo;Paccagnella;J Natl Cancer Inst,1994

3. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. French Groupe d'Etude des Tumeurs de la Tete et du Cou (GETTEC);Domenge;Br J Cancer,2000

4. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer;Posner;N Engl J Med,2007

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Cell Transcriptome Analysis Reveals Changes of Tumor Immune Microenvironment in Oral Squamous Cell Carcinoma After Chemotherapy;Frontiers in Cell and Developmental Biology;2022-06-17

2. p16-negatives Oropharynxkarzinom;Diagnostic Imaging: Onkologie;2022

3. Carcinome de l'oropharynx (p16[-]);Imagerie Oncologique;2022

4. Pathogenic TP53 mutations influence chemotherapy response and survival rate of HPV-negative oral carcinomas;Vojnosanitetski pregled;2021

5. Decline in circulating viral and human tumor markers after resection of head and neck carcinoma;Head & Neck;2020-08-28